| Table 1. Patients' characteristics in the two Groups receiving Prolutex or Cyclogest | |||||
| Variable | Level | Total | Treatment |
|
|
|---|---|---|---|---|---|
| Prolutex | Cyclogest | ||||
| Age | 20-25 25.1-30 30.1-35 35.1-40 |
24 (12.2%) 50 (25.4%) 53 (26.9%) 70 (35.5%) |
13 (13.4%) 32 (33.0%) 17 (17.5%) 35 (36.1%) |
11 (11.0%) 18 (18.0%) 36 (36.0%) 35 (35.0%) |
0.238 |
| BMI | 16-20 20.1-25 25.1-30 >30.1 |
13 (6.6%) 108 (54.8%) 57 (28.9%) 19 (9.6%) |
9 (9.3%) 63 (64.9%) 21 (21.6%) 4 (4.1%) |
4 (4.0%) 45 (45.0%) 36 (36.0%) 15 (15.0%) |
<0.001 |
| AFC | 11.87±5.97 | 11.77±6.82 | 0.912 | ||
| Infertility (Type) | Primary Secondary |
146 (74.1%) 51 (25.9%) |
79 (81.4%) 18 (18.6%) |
67 (67.0%) 33 (33.0%) |
0.021* |
| Infertility (Cause) | Male factor PCOS Age factor Uterine factor Tubual factor Mixed Other |
60 (30.5%) 10 (5.1%) 9 (4.6%) 3 (1.5%) 21 (10.7%) 66 (33.5%) 28 (14.2%) |
29 (29.9%) 5 (5.2%) 3 (3.1%) 3 (3.1%) 9 (9.3%) 30 (30.9%) 18 (18.6%) |
31 (31.0%) 5 (5.0%) 6 (6.0%) 0 (0.0%) 12 (12.0%) 36 (36.0%) 10 (10.0%) |
0.327** |
| Chemical Pregnancy | No chemical pregnancy Chemical pregnancy |
115 (58.4%) 82 (41.6%) |
57 (58.8%) 40 (41.2%) |
58 (58.0%) 42 (42.0%) |
0.914* |
‡ Based on Mann-Whitney test.
* Based on Chi-Square test.
** Based on Fisher exact test.